Prestige Biopharma IDC, the innovative drug research institute of Prestige Biopharma, announced that it has filed a patent for 'IDC224,' a next-generation subcutaneous (SC) delivery platform designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results